Skip to main content
$32.81 0.28 (0.86%)

High

$32.86

Low

$32.55

Trades

6,994

Turnover

$36,021,783

Volume

1,098,777
30 June 2023 at 4:12pm
If you were already registered, log in here.

[ARTICLE] Why Australia’s biggest and oldest LIC defied the Ozempic sell-off

A news article has been posted about ResMed Inc. on the AFR. The article was published around , on 24 January 2024 at 11:19am.

Australian Foundation Investment Company boss Mark Freeman says buying CSL and Resmed amid last year’s Ozempic rout was part of a tried-and-true strategy.

Read Article

RMD was $32.81 at the close of trade on 30 June 2023

Recent Articles about ASX:RMD
28-Oct AFIC NTA - Australian Foundation Investment Company

company-announcements.afr.com

26-Oct Issued October 2026 - AFR

company-announcements.afr.com

26-Oct 2026 Annual General Meeting (AGM) Chairman's Address and ...

company-announcements.afr.com

23-Oct FORM 4 - AFR

company-announcements.afr.com

21-Oct ASX Announcement - Australian United Investment Company Limited

company-announcements.afr.com

21-Oct FORM 4 - AFR

company-announcements.afr.com

21-Oct Appendix 4A - Statement of CDIs on issue - AFR

company-announcements.afr.com

20-Sep ResMed ASX Deferral of Conversions Announcement - AFR

company-announcements.afr.com

18-Sep PolyNovo Appoints Dean Phizacklea and Andrew Price as Non ...

company-announcements.afr.com

18-Sep Australian United Investment Company Limited - AFR

company-announcements.afr.com

Tracked

Find all articles about ResMed Inc., including others on the AFR, on the media page.

If you were already registered, log in here.

If you were already registered, log in here.

If you were already registered, log in here.